Finance

Lists
000950:SHE
C.Q. Pharmaceutical Holding Co Ltd
CNÂ¥5.58
+0.72%
(+0.040) 1D
Aug 28, 3:04:54 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000950...
Open
CNÂ¥5.52
High
CNÂ¥5.61
Low
CNÂ¥5.48
Mkt. cap
9.56B
Avg. vol.
42.81M
Volume
26.35M
Dividend
1.08%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
27.02
52-wk high
CNÂ¥7.41
52-wk low
CNÂ¥4.79
EPS
CNÂ¥0.21
Shares outstanding
1.71B
No. of employees
12K
Open
CNÂ¥5.52
High
CNÂ¥5.61
Low
CNÂ¥5.48
Mkt. cap
9.56B
Avg. vol.
42.81M
Volume
26.35M
Dividend
1.08%
Quarterly dividend
CNÂ¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
27.02
52-wk high
CNÂ¥7.41
52-wk low
CNÂ¥4.79
EPS
CNÂ¥0.21
Shares outstanding
1.71B
No. of employees
12K
About C.Q. Pharmaceutical Holding Co Ltd
CEO-
Employees12.2K
FoundedMay 28, 1999
Headquarters-
SectorHealth care provider
Websitecq-p.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
21.02B
20.24B
20.43B
19.70B
Cost of goods sold
19.53B
18.89B
19.03B
18.37B
Cost of revenue
19.53B
18.89B
19.03B
18.37B
Research and development expenses
-
354.97K
395.95K
-35.18K
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
937.15M
1.15B
812.02M
873.07M
Operating expense
1.19B
1.29B
1.11B
658.75M
Total operating expenses
20.72B
20.18B
20.14B
19.03B
Operating income
302.75M
51.72M
292.09M
666.29M
Other non operating income
-9.32M
-136.86M
-5.51M
-671.89M
EBT including unusual items
190.19M
14.42M
245.28M
172.85M
EBT excluding unusual items
202.69M
28.89M
230.14M
189.37M
Income tax expense
46.80M
25.47M
46.91M
58.69M
Effective tax rate
24.61%
176.61%
19.13%
33.95%
Other operating expenses
48.38M
50.20M
48.35M
33.19M
Net income
101.74M
2.70M
170.73M
83.72M
Net profit margin
0.48%
0.01%
0.84%
0.42%
Earnings per share
-
-
-
-
Interest and investment income
96.71M
285.43M
106.06M
194.97M
Interest expense
-187.45M
-171.42M
-162.50M
-
Net interest expenses
-90.74M
114.02M
-56.44M
194.97M
Depreciation and amortization charges
-
-
-
-
EBITDA
364.40M
116.81M
357.19M
730.38M
Gain or loss from assets sale
1.20M
-4.63M
-
-3.88M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps